Skip to content
PubMed This is a summary of 55 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 55 referenced papers

Top Authors

Vincent Cottin
Lyon 1 Université
Takafumi Suda
Hamamatsu University School of Medicine
Yuzo Suzuki
Hamamatsu University School of Medicine
Simon L. F. Walsh
Imperial College London
Jay Hoon Ryu
Mayo Clinic
Eunhee S. Yi
Mayo Clinic
Payam Mehrian
Masih Daneshvari Hospital
Yoshiyuki Oyama
Hamamatsu University School of Medicine
Hiroshi Hayakawa
National Hospital Organization
Koshi Yokomura
Seirei Mikatabara General Hospital

Top Institutions

Ranked by publications Top 10 institutions
05

Imperial College London

London, United Kingdom

9 papers
07

Iwata City Hospital

Iwata, Japan

3 papers
08

National Hospital Organization

Tokyo, Japan

3 papers
09

Seirei Mikatabara General Hospital

Hamamatsu, Japan

2 papers
Contributors Koshi Yokomura
10

Shizuoka City Shimizu Hospital

Shizuoka, Japan

2 papers
Contributors Masafumi Masuda

References

References (55)
  1. 1

    Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia.

    Oyama Y, Fujisawa T, Hashimoto D, et al.

    The European respiratory journal 2015; (45(6)):1624-31 doi:10.1183/09031936.00199614.

    PMID: 25614171
  2. 2

    Bronchial involvement in chronic eosinophilic pneumonia: a case report.

    Kim NH, Lee KH, Kim JH, et al.

    Journal of thoracic disease 2015; (7(4)):E97-E101 doi:10.3978/j.issn.2072-1439.2014.12.16.

    PMID: 25973261
  3. 3

    Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatment.

    Giovannini-Chami L, Blanc S, Hadchouel A, et al.

    Pediatric pulmonology 2016; (51(2)):203-16 doi:10.1002/ppul.23368.

    PMID: 26716396
  4. 4

    Eosinophilic Lung Diseases.

    Cottin V

    Clinics in chest medicine 2016; (37(3)):535-56.

    PMID: 27514599
  5. 5

    The Long-term Clinical Course of Chronic Eosinophilic Pneumonia.

    Ishiguro T, Takayanagi N, Uozumi R, et al.

    Internal medicine (Tokyo, Japan) 2016; (55(17)):2373-7 doi:10.2169/internalmedicine.55.6765.

    PMID: 27580536
  6. 6

    Chronic eosinophilic pneumonia: Adjunctive therapy with inhaled steroids.

    Chan C, DeLapp D, Nystrom P

    Respiratory medicine case reports 2017; (22()):11-14 doi:10.1016/j.rmcr.2017.05.014.

    PMID: 28626631
  7. 7

    Possible Role of IL-25 in Eosinophilic Lung Inflammation in Patients with Chronic Eosinophilic Pneumonia.

    Katoh S, Ikeda M, Matsumoto N, et al.

    Lung 2017; (195(6)):707-712 doi:10.1007/s00408-017-0048-8.

    PMID: 28875265
  8. 8

    Persistent impairment on spirometry in chronic eosinophilic pneumonia: A longitudinal observation study (Shizuoka-CEP study).

    Suzuki Y, Oyama Y, Hozumi H, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2017; (119(5)):422-428.e2 doi:10.1016/j.anai.2017.08.009.

    PMID: 28942952
  9. 9

    High-resolution computed tomography findings in chronic eosinophilic vs. cryptogenic organising pneumonia.

    Mehrian P, Doroudinia A, Rashti A, et al.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2017; (21(11)):1181-1186 doi:10.5588/ijtld.16.0723.

    PMID: 29037300
  10. 10

    Acute Eosinophilic Pneumonia. Causes, Diagnosis, and Management.

    De Giacomi F, Vassallo R, Yi ES, Ryu JH

    American journal of respiratory and critical care medicine 2018; (197(6)):728-736 doi:10.1164/rccm.201710-1967CI.

    PMID: 29206477
  11. 11

    Eosinophilic Pneumonias.

    Allen J, Wert M

    The journal of allergy and clinical immunology. In practice 2018; (6(5)):1455-1461 doi:10.1016/j.jaip.2018.03.011.

    PMID: 29735405
  12. 12

    Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia.

    Zimmermann N, Wikenheiser-Brokamp KA

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2018; (121(2)):179-185 doi:10.1016/j.anai.2018.05.014.

    PMID: 29803709
  13. 13

    Chronic Eosinophilic Pneumonia with Cardiac Involvement.

    Mansouri F, Moradmand S, Rakhshankhah A

    Tanaffos 2018; (17(2)):142-145.

    PMID: 30627188
  14. 14

    Chronic eosinophilic pneumonia: clinical perspectives.

    Crowe M, Robinson D, Sagar M, et al.

    Therapeutics and clinical risk management 2019; (15()):397-403 doi:10.2147/TCRM.S157882.

    PMID: 30936702
  15. 15

    The characterisation of interstitial lung disease multidisciplinary team meetings: a global study.

    Richeldi L, Launders N, Martinez F, et al.

    ERJ open research 2019; (5(2)) doi:10.1183/23120541.00209-2018.

    PMID: 30949489
  16. 16

    Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue Disease.

    Wells A, Devaraj A, Renzoni EA, Denton CP

    Seminars in respiratory and critical care medicine 2019; (40(2)):184-193 doi:10.1055/s-0039-1684020.

    PMID: 31137059
  17. 17

    10-Year Follow-Up of Frequently Relapsed Chronic Eosinophilic Pneumonia Starting at 15 Years Old; Attempts to Treat with Inhaled Corticosteroid (A Case Report).

    Murayama N, Doi S, Kameda M

    The American journal of case reports 2019; (20()):822-827 doi:10.12659/AJCR.915402.

    PMID: 31182706
  18. 18

    Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management.

    Suzuki Y, Suda T

    Allergology international : official journal of the Japanese Society of Allergology 2019; (68(4)):413-419 doi:10.1016/j.alit.2019.05.006.

    PMID: 31253537
  19. 19

    Allergic bronchopulmonary aspergillosis.

    Patel G, Greenberger PA

    Allergy and asthma proceedings 2019; (40(6)):421-424 doi:10.2500/aap.2019.40.4262.

    PMID: 31690385
  20. 20

    Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions.

    Harish A, Schwartz SA

    Clinical reviews in allergy & immunology 2020; (59(2)):231-247 doi:10.1007/s12016-019-08775-4.

    PMID: 31919743
  21. 21

    Possible Mechanisms of Eosinophil Accumulation in Eosinophilic Pneumonia.

    Nakagome K, Nagata M

    Biomolecules 2020; (10(4)) doi:10.3390/biom10040638.

    PMID: 32326200
  22. 22

    Rapid and sustained effects of a single dose of benralizumab on chronic eosinophilic pneumonia.

    Izumo T, Kuse N, Awano N, et al.

    Respiratory medicine case reports 2020; (30()):101062 doi:10.1016/j.rmcr.2020.101062.

    PMID: 32373456
  23. 23

    Biologics for the Treatment of Allergic Conditions: Eosinophil Disorders.

    Olivieri B, Tinazzi E, Caminati M, Lunardi C

    Immunology and allergy clinics of North America 2020; (40(4)):649-665 doi:10.1016/j.iac.2020.07.001.

    PMID: 33012326
  24. 24

    Hypersensitivity pneumonitis, allergic bronchopulmonary aspergillosis and other eosinophilic lung diseases.

    Barry J, Gadre A, Akuthota P

    Current opinion in immunology 2020; (66()):129-135 doi:10.1016/j.coi.2020.10.005.

    PMID: 33166785
  25. 25

    [Sertraline-induced chronic eosinophilic pneumonia].

    Brancaleone P, Descamps O, Piquet M, et al.

    Revue des maladies respiratoires 2021; (38(2)):210-214 doi:10.1016/j.rmr.2020.11.012.

    PMID: 33581985
  26. 26

    Idiopathic Chronic Eosinophilic Pneumonia.

    Teixeira N, Santos MI, Pedro F, et al.

    Cureus 2021; (13(3)):e14047 doi:10.7759/cureus.14047.

    PMID: 33898133
  27. 27

    Eosinophil extracellular traps in a patient with chronic eosinophilic pneumonia.

    Takeda M, Sakamoto S, Ueki S, et al.

    Asia Pacific allergy 2021; (11(3)):e24 doi:10.5415/apallergy.2021.11.e24.

    PMID: 34386400
  28. 28

    Clinical characteristics of patients with chronic eosinophilic pneumonia in a Chinese tertiary-care hospital: A 6-year retrospective study.

    Xu Y, Wang Z, Li W, et al.

    The clinical respiratory journal 2022; (16(1)):35-42 doi:10.1111/crj.13448.

    PMID: 34610651
  29. 29

    Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital.

    Eldaabossi SAM, Awad A, Anshasi N

    Respiratory medicine case reports 2021; (34()):101520 doi:10.1016/j.rmcr.2021.101520.

    PMID: 34692397
  30. 30

    Evaluating the relationship between high-resolution computed tomography findings and their extent in eosinophilic lung diseases with peripheral blood eosinophil level.

    Mehrian P, Kiani A, Bandegani N, et al.

    Polish journal of radiology 2021; (86()):e542-e547 doi:10.5114/pjr.2021.110643.

    PMID: 34820030
  31. 31

    Anti-IL-5 Agents for the Treatment of Idiopathic Chronic Eosinophilic Pneumonia: A Case Series.

    Tashiro H, Takahashi K, Kurihara Y, et al.

    Journal of asthma and allergy 2022; (15()):169-177 doi:10.2147/JAA.S343272.

    PMID: 35177908
  32. 32

    [Clinical analysis of chronic eosinophilic pneumonia in 9 cases].

    Zeng R, Liang ZT, Huang SY, et al.

    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2022; (45(4)):368-372 doi:10.3760/cma.j.cn112147-20211213-00881.

    PMID: 35381634
  33. 33

    Successful treatment of acute relapse of chronic eosinophilic pneumonia with benralizumab and without corticosteroids: A case report.

    Izhakian S, Pertzov B, Rosengarten D, Kramer MR

    World journal of clinical cases 2022; (10(18)):6105-6109 doi:10.12998/wjcc.v10.i18.6105.

    PMID: 35949821
  34. 34

    Idiopathic Chronic Eosinophilic Pneumonia Evolving to Pulmonary Fibrosis: A Retrospective Analysis.

    Baqir M, Peikert T, Johnson TF, et al.

    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2022; (39(2)):e2022020 doi:10.36141/svdld.v39i2.12656.

    PMID: 36118537
  35. 35

    Treatments of refractory eosinophilic lung diseases with biologics.

    Asano K, Suzuki Y, Tanaka J, et al.

    Allergology international : official journal of the Japanese Society of Allergology 2023; (72(1)):31-40 doi:10.1016/j.alit.2022.10.004.

    PMID: 36333218
  36. 36

    Predictive factors for relapse in corticosteroid-treated patients with chronic eosinophilic pneumonia.

    Takeuchi N, Arai T, Sasaki Y, et al.

    Journal of thoracic disease 2022; (14(11)):4352-4360 doi:10.21037/jtd-22-511.

    PMID: 36524087
  37. 37

    A case of chronic eosinophilic pneumonia associated with rheumatoid arthritis in glucocorticoid-free remission with JAK inhibitor: A case report.

    Yamane T, Hashiramoto A

    Medicine 2023; (102(13)):e33396 doi:10.1097/MD.0000000000033396.

    PMID: 37000107
  38. 38

    Eosinophilic Lung Diseases.

    Cottin V

    Immunology and allergy clinics of North America 2023; (43(2)):289-322 doi:10.1016/j.iac.2023.01.002.

    PMID: 37055090
  39. 39

    Pneumothorax with Eosinophilia is an Important Diagnostic Clue for Distinguishing Paragonimiasis from Chronic Eosinophilic Pneumonia: A Case Report.

    Sakakura S, Yamaguchi F, Abe T, et al.

    Infection and drug resistance 2023; (16()):2429-2432 doi:10.2147/IDR.S402392.

    PMID: 37138842
  40. 40

    Long-term use of mepolizumab in a case of chronic eosinophilic pneumonia: extending interval dosing.

    Prieto-García A, Peligros MI, Pérez Tamayo I, et al.

    The Journal of asthma : official journal of the Association for the Care of Asthma 2024; (61(1)):69-71 doi:10.1080/02770903.2023.2239343.

    PMID: 37467753
  41. 41

    Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia.

    Daboussi S, Essebaa S, Mhamdi S, et al.

    F1000Research 2023; (12()):337 doi:10.12688/f1000research.130939.3.

    PMID: 37691733
  42. 42

    Diagnostic journey of chronic eosinophilic pneumonia masked as lung cancer: a rare case report.

    Katwal S, Lamsal S, Bhandari S, Khanal S

    Annals of medicine and surgery (2012) 2023; (85(11)):5695-5698 doi:10.1097/MS9.0000000000001296.

    PMID: 37915693
  43. 43

    Critical deterioration of chronic eosinophilic pneumonia during pregnancy.

    Vernon-Elliot J, Prasad JD, Bonney A

    BMJ case reports 2024; (17(2)) doi:10.1136/bcr-2023-259019.

    PMID: 38395471
  44. 44

    Successful Treatment of Relapsing Chronic Eosinophilic Pneumonia With Mepolizumab: A Case Report.

    Worth L, Khreisat A, Iacobelli A

    Cureus 2024; (16(7)):e65097 doi:10.7759/cureus.65097.

    PMID: 39040614
  45. 45

    A Diagnostic Dilemma: Proteinase-3 (PR3)-Positive Anti-neutrophil Cytoplasmic Autoantibodies in Eosinophilic Granulomatosis With Polyangiitis.

    Goldman S, Wilson B, Awan K, et al.

    Cureus 2025; (17(3)):e80365 doi:10.7759/cureus.80365.

    PMID: 40206908
  46. 46

    Optimal dose of maintenance steroid therapy for relapse of chronic eosinophilic pneumonia: a multicentre retrospective study.

    Atsumi K, Nishima S, Tanaka T, et al.

    BMJ open respiratory research 2025; (12(1)) doi:10.1136/bmjresp-2024-002697.

    PMID: 40379264
  47. 47

    Chronic Eosinophilic Pneumonia With Overlapping Emphysema and Fibrosis: An Atypical Presentation of Recurrent Pulmonary Tuberculosis.

    Cardona A, Villa-Pérez S, Cohen-Mejía S, et al.

    Cureus 2025; (17(6)):e85228 doi:10.7759/cureus.85228.

    PMID: 40605869
  48. 48

    Eosinophilic Lung Diseases.

    Cottin V

    Clinics in chest medicine 2025; (46(4)):667-684 doi:10.1016/j.ccm.2025.07.007.

    PMID: 41110928
  49. 49

    Survey of physicians' approaches to the clinical evaluation of interstitial lung disease in Singapore (SoPhoCLES).

    Teo FSW, Chai GT, Low SY, et al.

    Journal of thoracic disease 2025; (17(11)):9439-9450 doi:10.21037/jtd-2025-1365.

    PMID: 41377003
  50. 50

    A Case of an 80-Year-Old Woman With Chronic Eosinophilic Pneumonia and Clinically Significant Giant Hepatic Hemangioma.

    Khazar V, Escobar S, Huang A, Szema AM

    Cureus 2025; (17(12)):e98917 doi:10.7759/cureus.98917.

    PMID: 41523533
  51. 51

    Idiopathic chronic eosinophilic pneumonia presenting as diffuse alveolar haemorrhage.

    Rana S, Choudhary R, Sharma A, et al.

    The National medical journal of India 2025; (38(6)):355-357.

    PMID: 41645984
  52. 52

    CT Findings of Asthma and Asthma-Mimicking Conditions.

    Al-Sergani AH, Zaini RH, Alsergani AH, et al.

    Cureus 2026; (18(5)):e108457 doi:10.7759/cureus.108457.

    PMID: 42261548
  53. 53

    Case Report: Chronic eosinophilic pneumonia with acute-like presentation and diagnostic challenges.

    Zamfir AS, Mihailovici AS, Mihai F, et al.

    Frontiers in medicine 2026; (13()):1841565 doi:10.3389/fmed.2026.1841565.

    PMID: 42318416
  54. 54

    Three-year sustained remission with mepolizumab in a rare eosinophilic disease: idiopathic chronic eosinophilic pneumonia.

    Akten HS, Inan S, Galata Z, et al.

    European clinical respiratory journal 2026; (13(1)):2705048 doi:10.1080/20018525.2026.2705048.

    PMID: 42591896
  55. 55

    New perspectives in the treatment of chronic eosinophilic pneumonia in the era of targeted therapies.

    Scelfo C, Simonazzi A, Ruggiero P, et al.

    Frontiers in immunology 2026; (17()):1893402 doi:10.3389/fimmu.2026.1893402.

    PMID: 42666554